Inloggad som:
CC90010-GBM-002
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
CC90010-GBM-002
A phase 1b, open-label, dose-finding study of CC-90010 in combination with temozolomide with or without radiation therapy in subjects with newly diagnosed glioblastoma
A phase 1b, open-label, dose-finding study of CC-90010 in combination with temozolomide with or without radiation therapy in subjects with newly diagnosed glioblastoma
PLACEHOLDER
Mer information om studien för vårdgivare
Studien ändrades senast av: studyjohanna (2023-03-19)